Delivery Order SPE2DB22D2206-SPE2DB23FKE39
Award Date 9/8/23
Potential Completion Date 9/29/23
Potential Value $93K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order under an undisclosed contract vehicle to AmerisourceBergen Drug Corporation for the supply of 21 capsules of the pharmaceutical FOTIVDA at 0.89 mg each. Valued at $15,596.18 with a firm fixed price, the order is to be performed in Conshohocken, Pennsylvania between August 22nd and September 13th, 2023. As a major provider of medical supplies and pharmaceuticals to the U.S. military, this order for cancer treatment medication supports the...
- The Defense Logistics Agency awarded a delivery order valued at thirty thousand eight hundred forty-one dollars and sixteen cents ($30,841.16) to Amerisourcebergen Drug Corporation for FOTIVDA 1.34 MG capsules. Under this firm fixed price contract, Amerisourcebergen will deliver twenty-one (21) capsules of the pharmaceutical product to a location in Conshohocken, Pennsylvania by August 24, 2023 in support of DLA programs. No major subcontractors or set aside designations were identified. This...
- The Defense Logistics Agency awarded a $18,186.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for FOTIVDA 1.34 mg capsule (21-count packages) with an ultimate completion date of January 23, 2026. This non-set-aside competitive award was issued on December 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a $15,953.54 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for FOTIVDA 1.34 mg capsules (21-count). This contract, which is non-set-aside and competitively awarded, is structured as a firm fixed price delivery order with a completion date of August 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FOTIVDA 0.89 mg capsules (21-count) on September 28, 2025, with a contract ceiling value of $64,177.48 and an ultimate completion date of October 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a pharmaceutical procurement supporting military and federal healthcare needs. The place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency issued a $17,245.62 delivery order to Amerisourcebergen Drug Corp on April 29, 2026, for FOTIVDA 1.34 MG capsules (pharmaceutical supply). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (SPE2DX series), which supports pharmaceutical prime vendor supply to Defense Health Agency and military medical facilities globally. Place of performance is Conshohocken, PA. The order has a firm fixed-price structure and an ultimate completion...
- <p>The Defense Logistics Agency issued a $17,245.62 delivery order to Amerisourcebergen Drug Corp on May 20, 2026, for FOTIVDA 1.34 MG capsules (21-count unit).</p> <p>The order is issued under a DLA Troop Support Medical indefinite delivery contract supporting pharmaceutical supply to Defense Health Agency and military medical facilities. Place of performance is Conshohocken, PA. The order carries a firm fixed price and ultimate completion date of June 11, 2026.</p>
- The Defense Logistics Agency issued a $17,245.62 delivery order to Amerisourcebergen Drug Corp on February 27, 2026, for FOTIVDA 1.34 MG capsules, with an ultimate completion date of March 20, 2026. The order is issued under a firm fixed-price structure with no set-aside. Place of performance is Conshohocken, PA. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor supplying federal medical procurement needs across the Defense Logistics Agency...
- The Defense Logistics Agency issued a $17,245.62 delivery order to Amerisourcebergen Drug Corp on March 19, 2026, for FOTIVDA 1.34 MG CAPSULE 21S pharmaceutical supply. The order was placed under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), valued at up to $999,999,999.00 and running through December 2026. This prime vendor contract enables supply of pharmaceutical products and medical commodities to support military healthcare programs worldwide. Place of performance...
- This is a $15,953.54 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FOTIVDA 1.34 MG CAPSULE 21S, with a performance period ending on July 28, 2025. The contract is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FKE39Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at ninety-three thousand fifty dollars and twenty-eight cents ($93,050.28) to Amerisourcebergen Drug Corporation for the supply of twenty-one (21) 0.89 mg capsules of FOTIVDA, an oncology drug. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania under the terms specified between September 8 and September 29, 2023. No set aside designation or subcontractors were indicated. This order is likely in support of the Defense Health Agency's mission to provide the Military Health System with worldwide class pharmaceuticals and medical supplies through the DLA's role as the Department of Defense's primary sourcing agent.
Generated 12/15/23, 9:49 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $93.1k | 9/8/23 |